Higher levels of oxidative DNA damage in cervical cells are correlated with the grade of dysplasia and HPV infection

Journal of Medical Virology

Volumn 88, Issue 2, 2016, Pages 336-344

  Visalli, Giuseppa ^a   Riso, Romana ^a   Facciolà, Alessio ^a   Mondello, Placido ^b   Caruso, Carmela ^a   Picerno, Isa ^a   Di Pietro, Angela ^a   Spataro, Pasquale ^a   Bertuccio, Maria Paola ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b Ospedali Riuniti Papardo Piemonte Hospital   (Italy)

Author keywords

8 Oxo 2 deoxyguanosine; Cervical lesions; High risk HPV; Human papillomavirus

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; MESSENGER RNA; PROTEIN E6; PROTEIN E7; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; 8-OXO-7-HYDRODEOXYGUANOSINE; BIOLOGICAL MARKER; DEOXYGUANOSINE; MUTAGENIC AGENT; ONCOPROTEIN;

ADULT; ARTICLE; CONDYLOMA; CONTROLLED STUDY; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 58; MAJOR CLINICAL STUDY; MIXED INFECTION; OXIDATIVE STRESS; PAPILLOMAVIRUS INFECTION; SMOKING; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; UTERINE CERVIX DYSPLASIA; ADOLESCENT; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; COMPLICATION; GENETICS; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; HUMANS; MIDDLE AGED; MUTAGENS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; UTERINE CERVICAL DYSPLASIA; YOUNG ADULT;

EID: 84954385927     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24327     Document Type: Article

References (62)

1. Akaike T, Okamoto S, Sawa T, Yoshitake J, Tamura F, Ichimori K, Miyazaki K, Sasamoto K, Maeda H. 2003. 8-nitroguanosine formation in viral pneumonia and its implication for pathogenesis. Proc Natl Acad Sci USA 100:685-690.
2. Almonte M, Albero G, Molano M, Carcamo C, García PJ, Pérez G. 2008. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine 26:16-36.
3. Ault KA. 2007. Human papillomavirus vaccines and the potential for cross-protection between related HPV types. Gynecol Oncol 107:S31-S33.
4. Baandrup L, Thomsen LT, Olesen TB, Andersen KK, Norrild B, Kjaer SK. 2014. The prevalence of human papillomavirus in colorectal adenomas and adenocarcinomas: A systematic review and meta-analysis. Eur J Cancer 50:1446-1461.
5. Bertuccio MP, Spataro P, Caruso C, Picerno I. 2011. Detection of human papillomavirus E6/E7 mRNA in women with high-risk HPV types 16, 18, 31, 33 and 45 which are associated with the development of human cervical cancer. Eur J Gynaecol Oncol 32:62-64.
6. Cullen AP, Reid R, Campion M, Lorincz AT. 1991. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 65:606-612.
7. Dandri M, Burda MR, Bürkle A, Zuckerman DM, Will H, Rogler CE, Greten H, Petersen J. 2002. Increase in de novo HBV DNA integrations in response to DNA oxidative damage or inhibition of poly(ADP-ribosyl) ation. Hepatology 35:217-223.
8. Darr D, Fridovich I. 1994. Free radicals in cutaneous biology. J Invest Dermatol 102:671-675.
9. De Marco F, Bucaj E, Foppoli C, Fiorini A, Blarzino C, Filipi K, Giorgi A, Schininà ME, Di Domenico F, Coccia R, Butterfield DA, Perluigi M. 2012. Oxidative stress in HPV-driven viral carcinogenesis: Redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues. PLoS ONE 7:e34366.
10. Di Domenico F, Foppoli C, Coccia R, Perluigi M. 2012. Antioxidants in cervical cancer: Chemopreventive and chemotherapeutic effects of polyphenols. Biochim Biophys Acta 1822:737-747.
11. Di Pietro A, Baluce B, Visalli G, La Maestra S, Micale R, Izzotti A. 2011. Ex vivo study for the assessment of behavioral factor and gene polymorphisms in individual susceptibility to DNA oxidative damage metals-induced. Int J Hyg Environ Health 214:210-218.
12. Dizdaroglu M, Jaruga P, Birincioglu M, Rodriguez H. 2002. Free radicalinduced damage toDNA: Mechanisms and measurement. Free Radic Biol Med 32:1102-1115. http://dx.doi.org/10.1016/S0891-5849(02)00826-2
13. Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. 2007. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121:2381-2386.
14. Ferro E, Visalli G, Civa R, La Rosa MA, Randazzo Papa G, Baluce B, D'Ascola DG, Piraino B, Salpietro C, Di Pietro A. 2012. Oxidative damage and genotoxicity biomarkers in transfused and untransfused thalassemic subjects. Free Radic Biol Med 53:1829-1837.
15. Finan RR, Musharrafieh U, Almawi WY. 2006. Detection of chlamydia trachomatis and herpes simplex virus type 1 or 2 in cervical samples in human papilloma virus (HPV)-positive and HPV-negative women. Clin Microbiol Infect 12:927-930.
16. Floyd RA. 1990. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 11:1447-1450.
17. Gervassi A, Alderson MR, Suchland R, Maisonneuve JF, Grabstein KH, Probst P. 2004. Differential regulation of inflammatory cytokine secretion by human dendritic cells upon Chlamydia trachomatis infection. Infect Immun 72:7231-7239.
18. Gillespie KA, Mehta KP, Laimins LA, Moody CA. 2012. Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J Virol 86:9520-9526. http://dx.doi.org/10.1128/JVI00247-12
19. Harrison DG, Widder J, Grumbach I, Chen W, Weber M, Searles C. 2006. Endothelial mechano-transduction, nitric oxide and vascular inflammation. J Intern Med 259:351-363.
20. Hawes SE, Kiviat NB. 2002. Are genital infections and inflammation cofactors in the pathogenesis of invasive cervical cancer? J Natl Cancer Inst 94:1592-1593.
21. Inoue S, Kawanishi S. 1995. DNA oxidative damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett 371:86-88.
22. Jeon S, Lambert PF. 1995. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis. Proc Natl Acad Sci USA 92:1654-1658.
23. Jurkiewicz BA, Buettner GR. 1994. Ultraviolet light-induced free radical formation in skin: An electron paramagnetic resonance study. Photochem Photobiol 59:1-4.
24. Kadaja M, Sumerina A, Verst T, Ojarand M, Ustav E, Ustav M. 2007. Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J 26:2180-2191.
25. Kawanishi S, Hiraku Y, Oikawa S. 2001. Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging. Mutat Res 488:65-76.
26. Kawanishi S, Hiraku Y, Pinlaor S, Ma N. 2006. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem 387:365-372.
27. Kim GE, Kim YB, Cho NH, Chung HC, Pyo HR, Lee JD, Park TK, Koom WS, Chun M, Suh CO. 2004. Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix. Clin Cancer Res 10:1366-1374.
28. Koike K. 2009. Hepatitis B virus X gene is implicated in liver carcinogenesis. Cancer Lett 286:60-68.
29. Kulkarni S, Rader JS, Zhang F, Liapis H, Koki AT, Masferrer JL, Subbaramaiah K, Dannenberg AJ. 2001. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res 7:429-434.
30. Lai D, Tan CL, Gunaratne J, Quek LS, Nei W, Thierry F, Bellanger S. 2013. Localization of HPV-18 E2 at mitochondrial membranes induces ROS release and modulates host cell metabolism. PLOS ONE 8:e75625.
31. Lowy D, Kirnbauer R, Schiller J. 1994. Genital human papillomavirus infection. PNAS 91:2436-2440.
32. Marnett LJ. 2000. Oxyradicals and DNA damage. Carcinogenesis 21:361-370.
33. Meloni A, Pilia R, Campagna M, Usai A, Masia G, Caredda V, Coppola RC. 2014. Prevalence and molecular epidemiology of human papillomavirus infection in Italian women with cervical cytological abnormalities. J Public Health Res 3:157. DOI: 10.4081/jphr.2014.157
34. Micale RT, La Maestra S, Di Pietro A, Visalli G, Baluce B, Balansky R, Steele VE, De Flora S. 2013. Oxidative stress in the lung of mice exposed to cigarette smoke either early in life or in adulthood. Arch Toxicol 87:915-918.
35. Muñoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX, International Agency for Research on Cancer, Multicentric Cervical Cancer Study Group. 2002. Role of parity and human papillomavirus in cervical cancer: The IARC multicentric case-control study. Lancet 359:1093-1101.
36. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiological classification of HPV types associated with cervical cancer. N Eng J Med 348:518-527.
37. Olinski R, Zastawny T, Budzbon J, Skokowski J, Zegarski W, Dizdaroglu M. 1992. DNA base modifications in chromatin of human cancerous tissues. FEBS Lett 309:193-198.
38. Okamoto K, Toyokuni S, Uchida K, Ogawa O, Takenewa J, Kakehi Y, Kinoshita H, Hattori-Nakakuki Y, Hiai H, Yoshida O. 1994. Formation of 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int J Cancer 58:825-829.
39. Paba P, Bonifacio D, Di Bonito L, Ombres D, Favalli C, Syrjänen K, Ciotti M. 2008. Co-expression of HSV2 and chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways. Intervirology 51:230-234.
40. Park EM, Park YM, Gwak YS. 1998. Oxidative damage in tissues of rats exposed to cigarette smoke. Free Radic Biol Med 25:79-86.
41. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
42. Parkin DM, Bray F. 2006. Chapter 2: The burden of HPV-related cancers. Vaccine 24:11-25.
43. Perez Castro S, Inarrea Fernandez A, Lamas Gonzalez MJ, Saran Diez MT, Cid Lama A, Alvarez Martin MJ, Pato Mosquera M, Lopez-Miragaya I, Estevez N, Torres Pinon J, Ona Navarro M. 2013. Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA. J Med Virol 85:1063-1068
44. Pirami L, Giachè V, Becciolini A. 1997. Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J Clin Pathol 50:600-604.
45. Pryor WA, Prier DG, Church DF. 1983. Electron-spin resonance study of mainstream and sidestream cigarette smoke: Nature of the free radicals in gas-phase smoke and in cigarette tar. Environ Health Perspect 47:345-355.
46. Romano G, Sgambato A, Mancini R, Capelli G, Giovagnoli MR, Flamini G, Boninsegna A, Vecchione A, Cittadini A. 2000. 8-hydroxy-2'-deoxyguanosine in cervical cells: Correlation with grade of dysplasia and human papillomavirus infection. Carcinogenesis 21:1143-1147.
47. Saldivar JS, Lopez D, Feldman RA, Tharappel-Jacob R, de la Rosa A, Terreros D, Baldwin WS. 2007. COX-2 overexpression as a biomarker of early cervical carcinogenesis: A pilot study. Gynecol Oncol 107:155-162.
48. Sies H. 1997. Oxidative stress: Oxidants and antioxidants. Exp Physiol 82:291-295.
49. Silins I, Ryd W, sezione A, Wadell G, Tornberg S, Hansson BG, Wang X, Arnheim L, Dahl V, Bremell D, Persson K, Dillner J, Rylander E. 2005. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 116:110-115.
50. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N. 2002. The 2001 Bethesda system: Terminology for reporting results of cervical cytology. Forum Group Members, Bethesda 2001 Workshop. JAMA 24:2114-2119.
51. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bültmann B. 2004. Detection and typing of human papillomavirus by E6 nested multiplex PCR. J Clin Microbiol 42:3176-3184. DOI: 10.1128/JCM.42.7.3176-3184.2004
52. Struthers L, Patel R, Clark J, Thomas S. 1998. Direct detection of 8-oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues. Anal Biochem 255:20-31.
53. Tindle RW. 2002. Immune evasion in human papillomavirus-associated cervical cancer. Nat Rev Cancer 2:59-65. http://dx.doi.org/10.1038/nrc700.
54. Tsai WL, Chung RT. 2010. Viral hepatocarcinogenesis. Oncogene 29:2309-2324.
55. Valko M, Morris H, Cronin MTD. 2005. Metals, toxicity and oxidative stress. Curr Med Chem 12:1161-1208.
56. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. 2006. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1-40.
57. Williams VM, Filippova M, Soto U, Duerksen-Hughes PJ. 2011. HPV-DNA integration and carcinogenesis: Putative roles for inflammation and oxidative stress. Future Virol 6:45-57.
58. Williams VM, Filippova M, Filippov V, Payne KJ, Duerksen-Hughes P. 2014. Human papillomavirus type 16 E6* induces oxidative stress and DNA damage. J Virol 88:6751-6761. DOI: 10.1128/JVI03355-13
59. Winder DM, Pett MR, Foster N, Shivji MK, Herdman MT, Stanley MA, Venkitaraman AR, Coleman N. 2007. An increase in DNA double-strand breaks, induced by Ku70 depletion, is associated with human papillomavirus 16 episome loss and de novo viral integration events. J Pathol 213:27-34. http://dx.doi.org/10.1002/path.2206
60. Yermilov V, Rubio J, Becchi M, Friesen MD, Pignatelli B, Ohshima H. 1995. Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. Carcinogenesis 16:2045-2050.
61. Zangar RC, Davydov DR, Verma S. 2004. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol 199:316-331.
62. Zur Hausen H. 2000. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92:690-698.